Breaking Down Axsome Therapeutics: 19 Analysts Share Their Views
Breaking Down Axsome Therapeutics: 19 Analysts Share Their Views
分解axsome therapeutics: 19位分析師分享他們的觀點
The standing of Axsome Therapeutics among financial experts becomes...In the preceding three months, 19 analysts have released ratings for Axsome Therapeutics (NASDAQ:AXSM), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，19位分析師發佈了對Axsome Therapeutics（納斯達克: AXSM）的評級，展示了從看好到看淡的多種觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他們最近的評級，展示了過去30天內的情緒演變並與之前的幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $128.05, a high estimate of $180.00, and a low estimate of $95.00. This current average has increased by 0.5% from the previous average price target of $127.41.
分析師分析的12個月目標價格提供了洞見，平均目標爲128.05美元，高估爲180.00美元，低估爲95.00美元。當前平均值比之前的127.41美元上漲了0.5%。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查：一項詳盡的研究
The standing of Axsome Therapeutics among financial experts becomes...
通過對最近分析師行...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。